Subcutaneous DMPA (DMPA-SC) is an innovative injectable contraceptive that can dramatically expand access and choice for women. The Injectables Access Collaborative (AC) provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.

The Access Collaborative is led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI.

For more information, visit the DMPA-SC Resource Library, Injectables Access Collaborative page, or email FPoptions@path.org.